Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

You are here

Genomics Data Details

Expand All

  • G-1 Increase the proportion of women with a family history of breast and/or ovarian cancer who receive genetic counseling

    About the Data

    Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

    Data Source: 
    National Health Interview Survey
    Changed Since the Healthy People 2020 Launch: 
    Yes
    Measure: 
    percent (age adjusted—see Comments)
    Baseline (Year): 
    34.6 (2005)
    Target: 
    38.1
    Target-Setting Method: 
    10 percent improvement
    Numerator: 

    Number of women aged 18 years and older who have ever discussed the possibility of getting a genetic test for cancer risk with a Health Care provider, who met the USPSTF criteria, based on first-degree relatives only, for BRCA1/2 genetic counseling referral, and who do not have a personal history of breast or ovarian cancer

    Denominator: 

    Number of women aged 18 years and older who met the USPSTF criteria, based on first-degree relatives only, for BRCA1/2 genetic counseling referral, and who do not have a personal history of breast or ovarian cancer

    Comparable Healthy People 2010 Objective: 
    Not applicable
    Questions Used to Obtain the National Baseline Data: 

      [NUMERATOR:]

      Have you EVER DISCUSSED the possibility of getting a genetic test for cancer risk with a doctor or other health professional?

      1. Yes
      2. No
      3. Refused
      4. Don't know

      [NUMERATOR AND DENOMINATOR:]

      What kind of cancer did your father have?

      1. Bladder
      2. Blood
      3. Bone
      4. Brain
      5. Breast
      6. Cervix
      7. Colon
      8. Esophagus
      9. Gallbladder
      10. Kidney
      11. Larynx-windpipe
      12. Leukemia
      13. Liver
      14. Lung
      15. Lymphoma
      16. Melanoma
      17. Mouth/tongue/lip
      18. Ovary
      19. Pancreas
      20. Prostate
      21. Rectum
      22. Skin (non melanoma)
      23. Skin (DK what kind)
      24. Soft tissue (muscle or fat)
      25. Stomach
      26. Testis
      27. Throat-pharynx
      28. Thyroid
      29. Uterus
      30. Other
      31. Refused
      32. Don't know

      What kind of cancer did your mother have?

      1. Bladder
      2. Blood
      3. Bone
      4. Brain
      5. Breast
      6. Cervix
      7. Colon
      8. Esophagus
      9. Gallbladder
      10. Kidney
      11. Larynx-windpipe
      12. Leukemia
      13. Liver
      14. Lung
      15. Lymphoma
      16. Melanoma
      17. Mouth/tongue/lip
      18. Ovary
      19. Pancreas
      20. Prostate
      21. Rectum
      22. Skin (non melanoma)
      23. Skin (DK what kind)
      24. Soft tissue (muscle or fat)
      25. Stomach
      26. Testis
      27. Throat-pharynx
      28. Thyroid
      29. Uterus
      30. Other
      31. Refused
      32. Don't know

      Was your biological mother under 50 years of age when [cancer type] was first diagnosed?

      1. Yes
      2. No
      3. Refused
      4. Don't know

      What kinds of cancer did your brother/brothers have?

      1. Bladder
      2. Blood
      3. Bone
      4. Brain
      5. Breast
      6. Cervix
      7. Colon
      8. Esophagus
      9. Gallbladder
      10. Kidney
      11. Larynx-windpipe
      12. Leukemia
      13. Liver
      14. Lung
      15. Lymphoma
      16. Melanoma
      17. Mouth/tongue/lip
      18. Ovary
      19. Pancreas
      20. Prostate
      21. Rectum
      22. Skin (non melanoma)
      23. Skin (DK what kind)
      24. Soft tissue (muscle or fat)
      25. Stomach
      26. Testis
      27. Throat-pharynx
      28. Thyroid
      29. Uterus
      30. Other
      31. Refused
      32. Don't know

      What kind of cancer did your sister/sisters have?

      1. Bladder
      2. Blood
      3. Bone
      4. Brain
      5. Breast
      6. Cervix
      7. Colon
      8. Esophagus
      9. Gallbladder
      10. Kidney
      11. Larynx-windpipe
      12. Leukemia
      13. Liver
      14. Lung
      15. Lymphoma
      16. Melanoma
      17. Mouth/tongue/lip
      18. Ovary
      19. Pancreas
      20. Prostate
      21. Rectum
      22. Skin (non melanoma)
      23. Skin (DK what kind)
      24. Soft tissue (muscle or fat)
      25. Stomach
      26. Testis
      27. Throat-pharynx
      28. Thyroid
      29. Uterus
      30. Other
      31. Refused
      32. Don't know

      Was your sister under 50 years of age when [cancer type] was first diagnosed?

      1. No
      2. Yes
      3. Refused
      4. Don't know

      How many of these sisters were under 50 years of age when [cancer type] was first diagnosed?

      1. None
      2. 1
      3. 2
      4. 3
      5. 4
      6. 5
      7. 6
      8. 7
      9. 8
      10. 9
      11. 10
      12. 11
      13. 12
      14. 13
      15. 14
      16. 15
      17. 16
      18. 17
      19. 18
      20. 19
      21. 20
      22. 21+
      23. Refused
      24. Don't know

      What kinds of cancer did your son/sons have?

      1. Bladder
      2. Blood
      3. Bone
      4. Brain
      5. Breast
      6. Cervix
      7. Colon
      8. Esophagus
      9. Gallbladder
      10. Kidney
      11. Larynx-windpipe
      12. Leukemia
      13. Liver
      14. Lung
      15. Lymphoma
      16. Melanoma
      17. Mouth/tongue/lip
      18. Ovary
      19. Pancreas
      20. Prostate
      21. Rectum
      22. Skin (non melanoma)
      23. Skin (DK what kind)
      24. Soft tissue (muscle or fat)
      25. Stomach
      26. Testis
      27. Throat-pharynx
      28. Thyroid
      29. Uterus
      30. Other
      31. Refused
      32. Don't know

      What kinds of cancer did your daughter/daughters have?

      1. Bladder
      2. Blood
      3. Bone
      4. Brain
      5. Breast
      6. Cervix
      7. Colon
      8. Esophagus
      9. Gallbladder
      10. Kidney
      11. Larynx-windpipe
      12. Leukemia
      13. Liver
      14. Lung
      15. Lymphoma
      16. Melanoma
      17. Mouth/tongue/lip
      18. Ovary
      19. Pancreas
      20. Prostate
      21. Rectum
      22. Skin (non melanoma)
      23. Skin (DK what kind)
      24. Soft tissue (muscle or fat)
      25. Stomach
      26. Testis
      27. Throat-pharynx
      28. Thyroid
      29. Uterus
      30. Other
      31. Refused
      32. Don't know

      Was your daughter under 50 years of age when [cancer type] was first diagnosed?

      1. No
      2. Yes
      3. Refused
      4. Don't know

      How many of these daughters were under 50 years of age when [cancer type] was first diagnosed?

      1. None
      2. 1
      3. 2
      4. 3
      5. 4
      6. 5
      7. 6
      8. 7
      9. 8
      10. 9
      11. 10
      12. 11
      13. 12
      14. 13
      15. 14
      16. 15
      17. 16
      18. 17
      19. 18
      20. 19
      21. 20
      22. 21+
      23. Refused
      24. Don't know
    Data Collection Frequency: 
    Periodic
    Methodology Notes: 

      The United States Preventive Services Task Force (USPSTF) issued an evidence-based statement in 2005 recommending that women whose family history is associated with an increased risk for deleterious mutations in BRCA1 or BRCA2 genes be referred for genetic counseling and evaluation for BRCA testing. Specific family history patterns identified by the USPSTF as associated with an increased risk for deleterious mutations in the BRCA1 and BRCA2 genes in non-Ashkenazi Jewish women include:
      2 first-degree relatives with breast cancer, 1 of whom received the diagnosis at age 50 years or younger;
      a combination of 3 or more first- or second-degree relatives with breast cancer regardless of age at diagnosis;
      a combination of both breast and ovarian cancer among first- and second-degree relatives;
      a first-degree relative with bilateral breast cancer;
      a combination of 2 or more first- or second-degree relatives with ovarian cancer regardless of age at diagnosis;
      a first- or second-degree relative with both breast and ovarian cancer at any age; and
      a history of breast cancer in a male relative.

      NHIS does not ascertain:
      1) Ashkenazi Jewish ancestry: analyses assume non-Ashkenazi Jewish ancestry;
      2) cancer history for second-degree relatives: only first-degree relatives are included in the analyses; and
      3) bilateral breast cancer: this USPSTF increased risk family history category is excluded from the analyses.

      Age Adjustment Notes: 

      This Indicator uses Age-Adjustment Groups:

      • Total: 18-44, 45-64, 65+
      • Race/Ethnicity: 18-44, 45-64, 65+
      • Educational Attainment: 25-44, 45-64, 65+
      • Family Income (percent poverty threshold): 18-44, 45-64, 65+
      • Family Type: 18-44, 45-64, 65+
      • Country of Birth: 18-44, 45-64, 65+
      • Disability Status: 18-44, 45-64, 65+
      • Geographic Location: 18-44, 45-64, 65+
      • Health Insurance Status: 18-44, 45-64
      • Marital Status: 18-44, 45-64, 65+

    Revision History

    Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

    Description of Changes Since the Healthy People 2020 Launch: 
    In 2013, the original baseline was revised from 23.3 to 34.6 due to a change in methodology that affects how missing and unknown survey responses are handled. The target was adjusted from 25.6 to 38.1 to reflect the revised baseline using the original target-setting method.

    References

    Additional resources about the objective

    1. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Ann Intern Med 2004;143:355-36
  • G-2 (Developmental) Increase the proportion of persons with newly diagnosed colorectal cancer who receive genetic testing to identify Lynch syndrome (or familial colorectal cancer syndromes)

    About the Data

    Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

    Potential Data Source: 
    National Program of Cancer Registries
    Surveillance, Epidemiology, and End Results Program
    Changed Since the Healthy People 2020 Launch: 
    No
    Measure: 
    percent
    Numerator: 

    *** Missing ***

    Comparable Healthy People 2010 Objective: 
    Not applicable